Earnings Call · Q3 FY2021·2021-11-10

Q3 21EPS +37.50%·Rev n/aQ2 21EPS -100.00%*·Rev n/aQ1 21EPS -100.00%*·Rev n/aQ4 20EPS -67.19%·Rev n/a⚠ consensus missing

ZEVRA THERAPEUTICS, INC. ZVRA

Jason Rando — Unknown, likely Investor Relations or Communications

Travis Mickle — Chief Executive Officer (CEO)

Rich Pascoe — Executive Chairman

LaDuane Clifton — Chief Financial Officer (CFO)

+2.9%1d on move date+2.8% vs SPY3d+0.8%5d−8.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ZVRA calls or request research access.

More ZVRA calls Browse calls Request research access